Literature DB >> 26829628

Serum amyloid A impairs the antiinflammatory properties of HDL.

Chang Yeop Han, Chongren Tang, Myriam E Guevara, Hao Wei, Tomasz Wietecha, Baohai Shao, Savitha Subramanian, Mohamed Omer, Shari Wang, Kevin D O'Brien, Santica M Marcovina, Thomas N Wight, Tomas Vaisar, Maria C de Beer, Frederick C de Beer, William R Osborne, Keith B Elkon, Alan Chait.   

Abstract

Year:  2016        PMID： 26829628      PMCID： PMC4731156          DOI： 10.1172/JCI86401

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  14 in total

1.  Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies.

Authors:  Jeremy D Furtado; Rain Yamamoto; John T Melchior; Allison B Andraski; Maria Gamez-Guerrero; Patrick Mulcahy; Zeling He; Tianxi Cai; W Sean Davidson; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-12       Impact factor: 8.311

2.  High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation.

Authors:  Preetha Shridas; Maria C De Beer; Nancy R Webb
Journal:  J Biol Chem       Date:  2018-07-05       Impact factor: 5.157

Review 3.  Cardiovascular disease in systemic lupus erythematosus.

Authors:  Maureen McMahon; Richard Seto; Brian J Skaggs
Journal:  Rheumatol Immunol Res       Date:  2021-12-15

4.  High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.

Authors:  Scott M Gordon; Jonathan H Chung; Martin P Playford; Amit K Dey; Denis Sviridov; Fayaz Seifuddin; Yun-Ching Chen; Mehdi Pirooznia; Marcus Y Chen; Nehal N Mehta; Alan T Remaley
Journal:  Atherosclerosis       Date:  2018-09-25       Impact factor: 5.162

5.  Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.

Authors:  R Kaseda; Y Tsuchida; J L Gamboa; J Zhong; L Zhang; H Yang; A Dikalova; A Bian; S Davies; A F Fogo; M F Linton; N J Brown; T A Ikizler; V Kon
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-03-08       Impact factor: 4.222

6.  HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.

Authors:  Mohamad O Ahmed; Rachel E Byrne; Agnieszka Pazderska; Ricardo Segurado; Weili Guo; Anjuli Gunness; Isolda Frizelle; Mark Sherlock; Khalid S Ahmed; Anne McGowan; Kevin Moore; Gerard Boran; Fiona C McGillicuddy; James Gibney
Journal:  Diabetologia       Date:  2020-11-09       Impact factor: 10.122

7.  Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis.

Authors:  C Charles-Schoeman; G B Gugiu; H Ge; A Shahbazian; Y Y Lee; X Wang; D E Furst; V K Ranganath; M Maldonado; Terry Lee; S T Reddy
Journal:  Atherosclerosis       Date:  2018-04-17       Impact factor: 6.847

Review 8.  High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy.

Authors:  Sang Yeop Kim; Minzhi Yu; Emily E Morin; Jukyung Kang; Mariana J Kaplan; Anna Schwendeman
Journal:  Arthritis Rheumatol       Date:  2019-11-26       Impact factor: 10.995

9.  High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke.

Authors:  Deanna L Plubell; Alex M Fenton; Sara Rosario; Paige Bergstrom; Phillip A Wilmarth; Wayne M Clark; Neil A Zakai; Joseph F Quinn; Jessica Minnier; Nabil J Alkayed; Sergio Fazio; Nathalie Pamir
Journal:  Circ Res       Date:  2020-08-26       Impact factor: 17.367

10.  Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm.

Authors:  Elena Burillo; Inmaculada Jorge; Diego Martínez-López; Emilio Camafeita; Luis Miguel Blanco-Colio; Marco Trevisan-Herraz; Iakes Ezkurdia; Jesús Egido; Jean-Baptiste Michel; Olivier Meilhac; Jesús Vázquez; Jose Luis Martin-Ventura
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.